해외 보도자료
-
- Access Advance Welcomes New VDP Pool Licensors and Releases Independent Economic Analysis Confirming FRAND Compliance
- Access Advance LLC today announced that Sharp Corporation, CB Cline, SK Planet, and Telechips, Inc have joined the Access Advance Video Distribution Patent Pool (VDP Pool) as Licensors, further expanding the pool’s portfolio of patents for modern ...
- 03월 24일 16:40
-
- AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs
- Galderma (SIX: GALD), the pure-play dermatology category leader, will present the latest updates on its innovations across its broad portfolio at the 2026 American Academy of Dermatology (AAD) Annual Meeting, taking place from March 27-31 in Denve...
- 03월 24일 16:39
-
- DFI Retail Partners with SymphonyAI to Drive AI-Driven Merchandising Capabilities
- DFI Retail , a leading Asian retailer has launched a pilot with SymphonyAI , a global leader in Vertical AI platforms, to evaluate advanced retail intelligence capabilities designed to enhance enterprise merchandise planning. The initiative reflec...
- 03월 24일 16:00
-
- Power Integrations Extends Flyback Topology to Enable 440 W, Offering Simpler Alternatives to Resonant Power Designs
- APEC 2026 - Power Integrations (NASDAQ: POWI ), the leader in high-voltage integrated circuits for energy-efficient power conversion, today introduced a breakthrough in flyback topology extending the power range of flyback converters to 440 W—well...
- 03월 24일 15:50
-
- The Estée Lauder Companies’ Statement on Potential Transaction with Puig
- The Estée Lauder Companies Inc. (NYSE: EL) confirms that it is in discussions regarding a potential business combination with Puig, in which the two companies would potentially merge their businesses. No final decision has been made, and no agreem...
- 03월 24일 15:30
-
- Biocytogen Announces Strategic Collaboration with Moonlight Bio to Advance Cell Therapies Using Library of Antibody Binders
- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic ...
- 03월 24일 15:20
-
- Starr Completes Acquisition of IQUW Group
- Starr, a global investment and insurance organization, today announced that it has completed its acquisition of IQUW Group, creating a broader, more diversified specialty (re)insurance platform with enhanced capabilities across the London market, ...
- 03월 24일 15:10
-
- RSA Launches ID Plus Sovereign Deployment: The Next Level of High Assurance Identity Security
- Today at RSAC Conference 2026, RSA, the security-first identity leader, announced the launch of RSA® ID Plus Sovereign Deployment , a groundbreaking evolution in high assurance identity solutions designed to meet the needs of organizations that mu...
- 03월 24일 14:45
-
- Faraday Highlights 40nm SONOS eNVM as NOR Flash Alternative for MCU Designs
- Faraday Technology Corporation (TWSE: 3035), a leading ASIC design service and IP provider, today highlighted its 40uLP SONOS embedded non-volatile memory (eNVM) solution, offering MCU vendors a cost-efficient alternative to NOR Flash while ensuri...
- 03월 24일 11:40
-
- Venture Global and Vitol Announce New LNG Purchase Agreement
- Today, Venture Global, Inc. (NYSE: VG) and Vitol announced the execution of a new, binding agreement for the purchase of approximately 1.5 million tonnes per annum (MTPA) of U.S. liquefied natural gas (LNG) from Venture Global for five years comme...
- 03월 24일 10:50
-
- Manhattan Associates’ 2026 Unified Commerce Benchmark Reveals the High Price of Standing Still in Retail
- Manhattan Associates Inc. (NASDAQ: MANH), today announced the findings of its 2026 Global Unified Commerce Benchmark for Specialty Retail , the industry’s most comprehensive assessment of how well retailers connect digital and physical experiences...
- 03월 24일 09:13
-
- Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing
- Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.[1,2] This builds on its previous approvals for...
- 03월 23일 15:50
전시회
